You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The most profound and enduring social theorist of sociology's classical period, Max Weber speaks as cogently to concerns of the new century as he did to those of the past. In Max Weber and the New Century, Alan Sica demonstrated Weber's preeminent position and lasting vitality within social theory by applying his ideas to a broad range of topics of contemporary concern. Max Weber: A Comprehensive Bibliography is a companion volume that offers some 4,600 bibliographic listings of work on Weber, making it the most complete guide to the literature in English and a testament to the continued vitality of Weber's thought. Sica's work supersedes all previous bibliographical efforts covering the Web...
Prior to 1862, when the Department of Agriculture was established, the report on agriculture was prepared and published by the Commissioner of Patents, and forms volume or part of volume, of his annual reports, the first being that of 1840. Cf. Checklist of public documents ... Washington, 1895, p. 148.
This book comprehensively reviews the current state of clinical trial methods in multiple sclerosis treatment, providing investigators, sponsors and specialists with current knowledge of outcome measures and study designs for disease and symptom management. The status of the rapidly evolving field of disease-modifying drugs is presented, with emphasis on the most promising therapies currently being tested. Experts discuss disease and symptom management for MS subtypes, including neuromyelitis optica and pediatric MS. In addition, key scientific advances in MS pathology, genetics, immunology and epidemiology are presented. The fourth edition has been extensively revised, featuring more than 50% new material. All chapters have been substantially updated to provide current information on rapidly evolving topics and this volume contains 15 new chapters, reflecting the growth of the field in recent years. This book is an essential reference for practitioners caring for MS patients, investigators planning or conducting clinical trials, and clinical trial sponsors.